{"section":{"filename":"s2412.html","chapter":"2400","section_number":"2412","title":"The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include a Sequence Listing in XML file format","revision_tag":"R-01.2024","bytes":189235,"sha256":"b44d413aa94bd5535646e4d62d87419abe66944760b855a2b5bcbba0f199ab65","subsection_count":18,"max_depth":2,"subsections":[{"number":"2412.01","title":"Overview of the Sequence Rules","revision_tag":"R-01.2024","depth":1},{"number":"2412.02","title":"Definition of “Sequence Listing XML”","revision_tag":"R-01.2024","depth":1},{"number":"2412.02(a)","title":"“Enumeration of its residues”","revision_tag":"R-01.2024","depth":2},{"number":"2412.03","title":"Nucleotides and Amino Acids Included and Excluded From a “Sequence Listing XML”","revision_tag":"R-01.2024","depth":1},{"number":"2412.03(a)","title":"“Specifically Defined”","revision_tag":"R-01.2024","depth":2},{"number":"2412.03(b)","title":"“Amino Acid”","revision_tag":"R-01.2024","depth":2},{"number":"2412.03(c)","title":"“Modified Amino Acid”","revision_tag":"R-01.2024","depth":2},{"number":"2412.03(d)","title":"“Nucleotide”","revision_tag":"R-01.2024","depth":2},{"number":"2412.03(e)","title":"“Modified Nucleotide”","revision_tag":"R-01.2024","depth":2},{"number":"2412.04","title":"Use of Sequence Identifiers to Denote Sequences Disclosed in the Description, Drawings or Claims","revision_tag":"R-01.2024","depth":1},{"number":"2412.05","title":"Representation and Symbols for Nucleotide and/or Amino Acid Sequences","revision_tag":"R-01.2024","depth":1},{"number":"2412.05(a)","title":"Use of Sequentially Numbered Sequence Identifiers in the “Sequence Listing XML”","revision_tag":"R-01.2024","depth":2},{"number":"2412.05(b)","title":"Representation and Symbols of Nucleotide Sequence Data","revision_tag":"R-01.2024","depth":2},{"number":"2412.05(c)","title":"Representation and Inclusion of Variants","revision_tag":"R-01.2024","depth":2},{"number":"2412.05(d)","title":"Representation and Symbols of Amino Acid Sequence Data","revision_tag":"R-01.2024","depth":2},{"number":"2412.05(e)","title":"Presentation of Special Situations","revision_tag":"R-01.2024","depth":2},{"number":"2412.06","title":"The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures","revision_tag":"R-01.2024","depth":1},{"number":"2412.07","title":"Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences","revision_tag":"R-07.2022","depth":1}]},"quality":"source","cited_authorities":null,"structured_data":null}